Athersys Inc (ATHX.OQ)

ATHX.OQ on NASDAQ Stock Exchange Capital Market

2.09USD
30 Jan 2015
Change (% chg)

$-0.13 (-5.86%)
Prev Close
$2.22
Open
$2.25
Day's High
$2.25
Day's Low
$2.08
Volume
81,289
Avg. Vol
112,379
52-wk High
$4.10
52-wk Low
$1.09

ATHX.OQ

Chart for ATHX.OQ

About

Athersys Inc. is a biopharmaceutical company engaged in the field of regenerative medicine. During the year ended December 31, 2011 the Company is developing its platform product, MultiStem, a allogeneic stem cell product that has been evaluated in two completed Phase I clinical trials and as of December 31, 2011, is being... (more)

Overall

Beta: 0.58
Market Cap(Mil.): $162.01
Shares Outstanding(Mil.): 77.52
Dividend: --
Yield (%): --

Financials

  ATHX.OQ Industry Sector
P/E (TTM): -- 188.86 38.54
EPS (TTM): -0.36 -- --
ROI: -109.25 -1.23 18.06
ROE: -132.19 -3.07 18.83
Search Stocks

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Pechala's Reports
$15.00
Provider: Pechala's Reports
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Thomson Reuters Stock Report
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks